Procept's Aquablation BPH Therapy Gets Boost From UK NICE Guidance

 
• By Reed Miller

The UK's NICE issued a recommendation approving Procept's AquaBeam Aquablation therapy as an alternative to surgical treatments for benign prostate hyperplasia just as a Medciare new technology add-on payment takes effect for Aquablation in the US.

UK flag on thumb up gesture like icon
• Source: shutterstock.com

More from Policy & Regulation

More from Medtech Insight